Gelteq Limited Ordinary Shares (GELS) Revenue History
Annual and quarterly revenue from 2020 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
GELS Revenue Growth
GELS Revenue Analysis (2020–2024)
As of May 8, 2026, Gelteq Limited Ordinary Shares (GELS) generated trailing twelve-month (TTM) revenue of $147,535. The most recent quarter (Q4 2024) recorded $0 in revenue.
Looking at the longer-term picture, GELS's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $147,536 in 2022.
When compared to Healthcare sector peers including DARE (-103.0% YoY), NUVB (+1205.5% YoY), and AQST (-22.6% YoY). Compare GELS vs DARE →
GELS Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| GELSCurrent | $147,535 | - | - | - | |
 DARE | $9,784 | -103.0% | - | -239692.2% | |
 NUVB | $63M | +1205.5% | - | -338.7% | |
 AQST | $45M | -22.6% | -0.6% | -159.5% |
GELS Historical Revenue Data (2020–2024)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $0 | -100.0% | $0 | - | $-2,945,975 | - |
| 2023 | $80K | -45.9% | $31K | 38.7% | $-3,102,151 | -3885.3% |
| 2022 | $148K | - | $53K | 35.7% | $-3,193,257 | -2164.4% |
| 2021 | $0 | - | $0 | - | $-647,624 | - |
| 2020 | $0 | - | $0 | - | $0 | - |
See GELS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs GELS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare GELS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonGELS — Frequently Asked Questions
Quick answers to the most common questions about buying GELS stock.
Is GELS's revenue growth accelerating or slowing?
GELS TTM revenue: $147535.00. YoY growth: N/A. 5-year CAGR: N/A.
What is GELS's long-term revenue growth rate?
Gelteq Limited Ordinary Shares's 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is GELS's revenue distributed by segment?
GELS reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2020-2024 are available for download. Segment mix reveals concentration and diversification trends.